Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients With Acute Kidney Injury Requiring Continuous Kidney Replacement Therapy

NCT05758077 is registered in ClinicalTrials.gov with SeaStar Medical as lead sponsor.

NCT NCT05758077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05758077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients With Acute Kidney Injury Requiring Continuous Kidney Replacement Therapy
Lead sponsor
SeaStar Medical
Phase
Not applicable
Overall status
Recruiting
Start date
April 17, 2023
Completion date
June 30, 2027
Enrollment
339 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury